Insider Profile
Lerner, Stuart
1
Companies Filed At
0
Open-Market Buys (2yr)
—
Buy Value (2yr, open-market)
Jun 21, 2024
Most Recent Trade
56
Credibility
Score
73%
Hit Rate
+10.3%
Avg 90d Return
+11.5%
Median 90d Return
30
Evaluated Trades
+30.7%
Best Trade
-11.5%
Worst Trade
Hit rate and returns are based on 30 open-market buys with evaluable 90-day outcomes. Score reflects historical conviction, not a guarantee of future performance. This insider has a solid track record of profitable timing.
Cross-Company Track Record
75%
Hit Rate · 90d
+0.8%
Median Alpha · 90d
4
Closed Buys Evaluated
50%
Beat XIU
All-insider base rate: 59% hit rate  · +1.3% mean alpha (n=11504)
size concentrated
Entry: closing price on SEDI filing date (point-in-time). Exit: 90 calendar days later. Alpha vs XIU.TO (iShares TSX 60). Closed trades only. Not investment advice.
Research 4 closed buys with individual return outcomes available on the Research plan.
Date Company Role Nature Dir. Shares Price Value Score
Jun 21, 2024 $STN
Stantec
— Other Sell 2,610 $115.10 $300K 63
Jun 21, 2024 $STN
Stantec
— Other Sell 10,438 $174.15 $1.8M 63
Dec 31, 2023 $STN
Stantec
— Plan / DRIP Buy 275 $89.79 $25K 63
Dec 31, 2023 $STN
Stantec
— Plan / DRIP Buy 68 $89.79 $6K 63
Jun 23, 2023 $STN
Stantec
— Other Sell 8,576 $101.22 $868K 63
Jun 23, 2023 $STN
Stantec
— Other Sell 2,143 $82.16 $176K 63
May 15, 2023 $STN
Stantec
— Comp. Grant Buy 2,318 $80.64 $187K 63
May 15, 2023 $STN
Stantec
— Comp. Grant Buy 9,268 $80.64 $747K 63
Mar 22, 2023 $STN
Stantec
— Open Market Buy 8,580 $77.12 $662K 63
Mar 22, 2023 $STN
Stantec
— Exercise Sell 11,540 $32.98 $381K 63
Mar 22, 2023 $STN
Stantec
— Exercise Buy 11,540 $32.98 $381K 63
Dec 31, 2022 $STN
Stantec
— Plan / DRIP Buy 335 $62.67 $21K 63
Dec 31, 2022 $STN
Stantec
— Plan / DRIP Buy 84 $62.67 $5K 63
Dec 31, 2022 $STN
Stantec
— Plan / DRIP Buy 2,284 $47.54 $109K 63
Jun 24, 2022 $STN
Stantec
— Other Sell 1,427 $55.38 $79K 63
Jun 24, 2022 $STN
Stantec
— Other Sell 5,707 $49.07 $280K 63
May 16, 2022 $STN
Stantec
— Comp. Grant Buy 2,990 $54.50 $163K 63
May 16, 2022 $STN
Stantec
— Comp. Grant Buy 11,956 $54.50 $652K 63
Mar 14, 2022 $STN
Stantec
— Exercise Sell 8,071 $31.75 $256K 63
Mar 14, 2022 $STN
Stantec
— Open Market Buy 6,453 $63.55 $410K 63
Mar 14, 2022 $STN
Stantec
— Exercise Buy 8,071 $31.75 $256K 63
Dec 31, 2021 $STN
Stantec
— Plan / DRIP Buy 234 $60.97 $14K 63
Dec 31, 2021 $STN
Stantec
— Plan / DRIP Buy 1,943 $42.34 $82K 63
Dec 31, 2021 $STN
Stantec
— Plan / DRIP Buy 62 $47.07 $3K 63
Dec 31, 2021 $STN
Stantec
— Comp. Grant Buy 10,129 $53.45 $541K 63
Dec 31, 2021 $STN
Stantec
— Comp. Grant Buy 2,533 $53.45 $135K 63
Dec 31, 2021 $STN
Stantec
— Plan / DRIP Buy 59 $60.97 $4K 63
Apr 30, 2021 $STN
Stantec
— Ownership Chg Buy 6,845 — — 63
Apr 30, 2021 $STN
Stantec
— Ownership Chg Sell 6,845 — — 63
Apr 23, 2021 $STN
Stantec
— Other Sell 4,196 $38.58 $162K 63
Mar 08, 2021 $STN
Stantec
— Exercise Sell 7,158 $32.83 $235K 63
Mar 08, 2021 $STN
Stantec
— Open Market Buy 6,303 $51.58 $325K 63
Mar 08, 2021 $STN
Stantec
— Exercise Buy 7,158 $32.83 $235K 63
Dec 31, 2020 $STN
Stantec
— Comp. Grant Buy 2,068 $42.00 $87K 63
Dec 31, 2020 $STN
Stantec
— Plan / DRIP Buy 594 $28.91 $17K 63
Dec 31, 2020 $STN
Stantec
— Plan / DRIP Buy 83 $32.17 $3K 63
Dec 31, 2020 $STN
Stantec
— Plan / DRIP Buy 237 $41.80 $10K 63
Dec 31, 2020 $STN
Stantec
— Plan / DRIP Buy 44 $41.88 $2K 63
Dec 31, 2020 $STN
Stantec
— Comp. Grant Buy 8,274 $42.00 $348K 63
Nov 23, 2020 $STN
Stantec
— Open Market Buy 2,642 $39.29 $104K 63
Nov 23, 2020 $STN
Stantec
— Exercise Sell 2,770 $32.90 $91K 63
Nov 23, 2020 $STN
Stantec
— Exercise Buy 2,770 $32.90 $91K 63
Apr 24, 2020 $STN
Stantec
— Other Sell 2,677 $39.84 $107K 63
Muted rows are plan purchases, compensation grants, or DRIP — not open-market. Confluence Scores reflect the company's current score, not the score at time of trade.
Form55 provides data and analysis for informational purposes only. Nothing on this site constitutes investment advice or a recommendation to buy or sell any security. Past performance is not indicative of future results.